-Bloomberg
Barclays Initiates Coverage On Medtronic with Equal-Weight Rating, Announces Price Target of $90
Barclays analyst Matt Miksic initiates coverage on Medtronic (NYSE:MDT) with a Equal-Weight rating and announces Price Target of $90.